Avi Raveh

768 total citations
16 papers, 573 citations indexed

About

Avi Raveh is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Avi Raveh has authored 16 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pharmacology and 3 papers in Organic Chemistry. Recurrent topics in Avi Raveh's work include Microbial Natural Products and Biosynthesis (7 papers), Alzheimer's disease research and treatments (3 papers) and Marine Sponges and Natural Products (3 papers). Avi Raveh is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Alzheimer's disease research and treatments (3 papers) and Marine Sponges and Natural Products (3 papers). Avi Raveh collaborates with scholars based in Israel, United States and Costa Rica. Avi Raveh's co-authors include Shmuel Carmeli, David H. Sherman, Hamutal Engel, Ehud Gazit, Pamela J. Schultz, Edward Pichinuk, Michael Cais, Teatulohi Matainaho, Daniel Segal and Sean A. Newmister and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Avi Raveh

16 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avi Raveh Israel 14 227 187 171 101 72 16 573
Paula Kiuru Finland 15 184 0.8× 146 0.8× 86 0.5× 71 0.7× 15 0.2× 29 594
Nelson Huang United States 9 211 0.9× 128 0.7× 169 1.0× 70 0.7× 7 0.1× 12 561
Aline Cavalcanti de Queiroz Brazil 17 219 1.0× 179 1.0× 60 0.4× 62 0.6× 32 0.4× 49 791
F. Favier France 20 861 3.8× 52 0.3× 90 0.5× 57 0.6× 84 1.2× 40 1.3k
Andrew C. Eliot United States 14 855 3.8× 276 1.5× 170 1.0× 73 0.7× 20 0.3× 18 1.2k
Lona M. Alkhalaf United Kingdom 10 312 1.4× 123 0.7× 160 0.9× 40 0.4× 39 0.5× 15 536
Jack B. Deeter United States 17 451 2.0× 834 4.5× 230 1.3× 125 1.2× 14 0.2× 33 1.4k
Dong-Woo Shin United States 9 302 1.3× 200 1.1× 154 0.9× 37 0.4× 195 2.7× 21 638
Makoto Shibata Japan 11 253 1.1× 359 1.9× 111 0.6× 95 0.9× 28 0.4× 31 662
John W. Wong United States 17 583 2.6× 334 1.8× 94 0.5× 49 0.5× 7 0.1× 33 970

Countries citing papers authored by Avi Raveh

Since Specialization
Citations

This map shows the geographic impact of Avi Raveh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi Raveh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi Raveh more than expected).

Fields of papers citing papers by Avi Raveh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avi Raveh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi Raveh. The network helps show where Avi Raveh may publish in the future.

Co-authorship network of co-authors of Avi Raveh

This figure shows the co-authorship network connecting the top 25 collaborators of Avi Raveh. A scholar is included among the top collaborators of Avi Raveh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avi Raveh. Avi Raveh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Peretz, Asher, Adva Yeheskel, Hamutal Engel, et al.. (2022). Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K + channels for atrial fibrillation treatment. Proceedings of the National Academy of Sciences. 119(34). e2202926119–e2202926119. 15 indexed citations
2.
Bar‐Yosef, Dana Laor, Shira Shaham‐Niv, Dor Zaguri, et al.. (2019). Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulation. Nature Communications. 10(1). 62–62. 43 indexed citations
3.
Arad, Elad, Chen Shemesh, Edward Pichinuk, et al.. (2019). Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model. Cellular and Molecular Life Sciences. 77(14). 2795–2813. 56 indexed citations
4.
Velayudhannair, Krishnakumar, Edward Pichinuk, Hamutal Engel, et al.. (2018). Integrating in vitro and in silico approaches to evaluate the “dual functionality” of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(7). 1565–1575. 39 indexed citations
5.
Cao, Shugeng, Avi Raveh, Ryan MacArthur, et al.. (2015). Actinoramide A Identified as a Potent Antimalarial from Titration-Based Screening of Marine Natural Product Extracts. Journal of Natural Products. 78(10). 2411–2422. 28 indexed citations
6.
Li, Shasha, Andrew N. Lowell, Fengan Yu, et al.. (2015). Hapalindole/Ambiguine Biogenesis Is Mediated by a Cope Rearrangement, C–C Bond-Forming Cascade. Journal of the American Chemical Society. 137(49). 15366–15369. 61 indexed citations
7.
Raveh, Avi, Pamela J. Schultz, Colleen Carpenter, et al.. (2014). Identification of Protein Kinase C Activation as a Novel Mechanism for RGS2 Protein Upregulation through Phenotypic Screening of Natural Product Extracts. Molecular Pharmacology. 86(4). 406–416. 17 indexed citations
8.
Delekta, Phillip C., Avi Raveh, Martha J. Larsen, et al.. (2014). The Combined Use of Alphavirus Replicons and Pseudoinfectious Particles for the Discovery of Antivirals Derived from Natural Products. SLAS DISCOVERY. 20(5). 673–680. 6 indexed citations
9.
Raveh, Avi, Sue‐Ann Mok, Thomas J. McQuade, et al.. (2014). High‐Throughput Screen of Natural Product Extracts in A Yeast Model of Polyglutamine Proteotoxicity. Chemical Biology & Drug Design. 83(4). 440–449. 13 indexed citations
10.
Raveh, Avi, Phillip C. Delekta, Craig J. Dobry, et al.. (2013). Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria. PLoS ONE. 8(12). e82318–e82318. 70 indexed citations
11.
Raveh, Avi, et al.. (2011). Protease inhibitors from three fishpond water blooms of Microcystis spp.. Tetrahedron. 67(22). 4017–4024. 23 indexed citations
12.
Raveh, Avi, et al.. (2010). Novel thiazole and oxazole containing cyclic hexapeptides from a waterbloom of the cyanobacterium Microcystis sp.. Tetrahedron. 66(14). 2705–2712. 23 indexed citations
13.
Raveh, Avi & Shmuel Carmeli. (2010). Aeruginazole A, a Novel Thiazole-Containing Cyclopeptide from the Cyanobacterium Microcystis sp.. Organic Letters. 12(15). 3536–3539. 24 indexed citations
14.
Raveh, Avi & Shmuel Carmeli. (2008). Two novel biological active modified peptides from the cyanobacterium Microcystis sp.. Phytochemistry Letters. 2(1). 10–14. 16 indexed citations
15.
Raveh, Avi & Shmuel Carmeli. (2007). Antimicrobial Ambiguines from the Cyanobacterium Fischerella sp. Collected in Israel. Journal of Natural Products. 70(2). 196–201. 105 indexed citations
16.
Cais, Michael, et al.. (1965). Organometallic Studies. XVII.1 A Novel Approach to the Synthesis of the Benzopentalene System2. Journal of the American Chemical Society. 87(24). 5607–5614. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026